Free shipping on all orders over $ 500

A-485

Cat. No. M9561
A-485 Structure
Size Price Availability Quantity
5mg USD 275  USD275 In stock
10mg USD 415  USD415 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

A-485 is a potent and selective HAT inhibitor of p300/CBP in vitro with an IC50 of 10 nM in a p300 TR-FRET assay and 3 nM in a CBP TR-FRET assay with selectivity > 1000-fold over closely related HATs. A-485 exhibits potent activity in most multiple myeloma cell lines, and in a subset of acute myeloid leukaemia lines and non-Hodgkin’s lymphoma lines. A-485 induces a comparable decrease in H3K27Ac in all five prostate cancer cell lines.

In tumour-bearing animals, dosing with A-485 for seven days induces a decrease in the mRNA levels of MYC and the AR-dependent gene SLC45A3 at three hours post-dosing, and (for MYC) a decrease in the protein level, indicating that A-485 inhibits p300-mediated transcriptional activity in vivo.

Chemical Information
Molecular Weight 536.48
Formula C25H24F4N4O5
CAS Number 1889279-16-6
Solubility (25°C) DMSO ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Shicheng Huo, et al. p300/CBP inhibitor A-485 inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss

[2] Feiye Zhou, et al. Selective inhibition of CBP/p300 HAT by A-485 results in suppression of lipogenesis and hepatic gluconeogenesis

[3] Jinjin Peng, et al. p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization

[4] Loren M Lasko, et al. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Related Histone Acetyltransferase Products
AU-18069

AU-18069 is a CBP/p300 HAT inhibitor that can be used in studies related to hematological and solid tumors.

KAT modulator-1

KAT modulator-1 is a KAT modulator.

KAT6-IN-1

KAT6-IN-1 is a potent KAT6 inhibitor.

MC4171

MC4171 is a selective KAT8 inhibitor (IC50=8.1 µM).

MOZ-IN-3

MOZ-IN-3 is a KAT6A (MOZ) acetyltransferase inhibitor (IC50: 30 nM).

  Catalog
Abmole Inhibitor Catalog




Keywords: A-485 supplier, Histone Acetyltransferase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.